Structural and functional brain imaging in schizophrenia.
We present an evaluation of the contribution of structural and functional brain imaging to our understanding of schizophrenia. Methodological influences on the validity of the data generated by these new technologies include problems with measurement and clinical and anatomic heterogeneity. These considerations greatly affect the interpretation of the data generated by these technologies. Work in these fields to date, however, has produced strong evidence which suggests that schizophrenia is a disease which involves abnormalities in the structure and function of many brain areas. Structural brain imaging studies of schizophrenia using computed tomography (CT) and magnetic resonance imaging (MRI) are reviewed and their contribution to current theories of the pathogenesis of schizophrenia are discussed. Positron emission tomography (PET) studies of brain metabolic activity and dopamine receptor binding in schizophrenia are summarized and the critical questions raised by these studies are outlined. Future studies in these fields have the potential to yield critical insights into the pathophysiology of schizophrenia; new directions for studies of schizophrenia using these technologies are identified.
Cleghorn
J M
JM
Clarke Institute of Psychiatry, Toronto, Ontario.
Zipursky
R B
RB
List
S J
SJ
D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D011954:Receptors, Dopamine / Q000378:metabolism; D012559:Schizophrenia / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology*; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed
D011954:Receptors, Dopamine